Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs PIRAMAL ENTERPRISES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB PIRAMAL ENTERPRISES DR. REDDYS LAB/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 20.1 -28.8 - View Chart
P/BV x 3.8 0.6 647.7% View Chart
Dividend Yield % 0.7 3.8 18.2%  

Financials

 DR. REDDYS LAB   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-22
PIRAMAL ENTERPRISES
Mar-22
DR. REDDYS LAB/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs5,6143,013 186.3%   
Low Rs3,6551,612 226.7%   
Sales per share (Unadj.) Rs1,294.6586.3 220.8%  
Earnings per share (Unadj.) Rs126.956.4 225.0%  
Cash flow per share (Unadj.) Rs196.984.3 233.6%  
Dividends per share (Unadj.) Rs30.0033.00 90.9%  
Avg Dividend yield %0.61.4 45.4%  
Book value per share (Unadj.) Rs1,145.81,487.0 77.1%  
Shares outstanding (eoy) m166.43238.66 69.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.63.9 90.8%   
Avg P/E ratio x36.541.0 89.0%  
P/CF ratio (eoy) x23.527.4 85.8%  
Price / Book Value ratio x4.01.6 260.1%  
Dividend payout %23.658.5 40.4%   
Avg Mkt Cap Rs m771,272551,910 139.7%   
No. of employees `000NANA-   
Total wages/salary Rs m38,85821,350 182.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m215,452139,933 154.0%  
Other income Rs m4,8477,201 67.3%   
Total revenues Rs m220,299147,134 149.7%   
Gross profit Rs m37,67462,822 60.0%  
Depreciation Rs m11,6526,658 175.0%   
Interest Rs m95844,799 2.1%   
Profit before tax Rs m29,91118,567 161.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,7895,108 172.1%   
Profit after tax Rs m21,12213,459 156.9%  
Gross profit margin %17.544.9 38.9%  
Effective tax rate %29.427.5 106.8%   
Net profit margin %9.89.6 101.9%  
BALANCE SHEET DATA
Current assets Rs m177,880251,882 70.6%   
Current liabilities Rs m97,658195,756 49.9%   
Net working cap to sales %37.240.1 92.8%  
Current ratio x1.81.3 141.6%  
Inventory Days Days561,969 2.8%  
Debtors Days Days1134 2,674.7%  
Net fixed assets Rs m106,819816,105 13.1%   
Share capital Rs m832477 174.3%   
"Free" reserves Rs m189,859354,414 53.6%   
Net worth Rs m190,691354,891 53.7%   
Long term debt Rs m5,746437,784 1.3%   
Total assets Rs m284,6991,067,987 26.7%  
Interest coverage x32.21.4 2,278.1%   
Debt to equity ratio x01.2 2.4%  
Sales to assets ratio x0.80.1 577.6%   
Return on assets %7.85.5 142.2%  
Return on equity %11.13.8 292.1%  
Return on capital %15.78.0 196.6%  
Exports to sales %47.10-   
Imports to sales %18.80.2 8,703.1%   
Exports (fob) Rs m101,544NA-   
Imports (cif) Rs m40,401302 13,400.0%   
Fx inflow Rs m101,5441,125 9,023.7%   
Fx outflow Rs m40,401302 13,400.0%   
Net fx Rs m61,143824 7,422.1%   
CASH FLOW
From Operations Rs m28,10887,496 32.1%  
From Investments Rs m-26,387-22,262 118.5%  
From Financial Activity Rs m-2,422-69,880 3.5%  
Net Cashflow Rs m327,000 0.5%  

Share Holding

Indian Promoters % 26.7 43.5 61.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 50.7 39.3 128.9%  
FIIs % 27.3 31.3 87.3%  
ADR/GDR % 10.5 0.0 -  
Free float % 62.8 56.5 111.1%  
Shareholders   246,788 265,213 93.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   SUN PHARMA    CIPLA    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    


More on Dr. Reddys vs Piramal Enterprises

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs Piramal Enterprises Share Price Performance

Period Dr. Reddys Piramal Enterprises S&P BSE HEALTHCARE
1-Day -0.25% 3.11% -1.00%
1-Month 2.87% 3.95% -4.34%
1-Year -0.33% -65.07% -10.74%
3-Year CAGR 11.53% -13.23% 17.21%
5-Year CAGR 15.62% -19.33% 9.46%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the Piramal Enterprises share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of Piramal Enterprises the stake stands at 43.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of Piramal Enterprises.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 23.6%.

Piramal Enterprises paid Rs 33.0, and its dividend payout ratio stood at 58.5%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of Piramal Enterprises.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Gains 400 Points | Adani Group Stocks See Further Selloff | Titan Rallies 5%, Adani Enterprises Cracks 35% Sensex Today Gains 400 Points | Adani Group Stocks See Further Selloff | Titan Rallies 5%, Adani Enterprises Cracks 35%(10:30 am)

Asian share markets are higher today in cautious trading after disappointing earnings from some big-tech names weighed on sentiment following a surge in US equities.